NO20071706L - Koadministrering av Tigecycline og Digoxin. - Google Patents

Koadministrering av Tigecycline og Digoxin.

Info

Publication number
NO20071706L
NO20071706L NO20071706A NO20071706A NO20071706L NO 20071706 L NO20071706 L NO 20071706L NO 20071706 A NO20071706 A NO 20071706A NO 20071706 A NO20071706 A NO 20071706A NO 20071706 L NO20071706 L NO 20071706L
Authority
NO
Norway
Prior art keywords
tigecycline
digoxin
administration
administered
human
Prior art date
Application number
NO20071706A
Other languages
English (en)
Inventor
Donald G Raible
Gopal Muralidharan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20071706L publication Critical patent/NO20071706L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

Oppfinnelsen angår behandling av bakterieinfeksjoner med tigecyklin og hjerte- insuffisiens med digoksin ved koadministrering til et menneske med behov for dette.
NO20071706A 2004-10-28 2007-03-30 Koadministrering av Tigecycline og Digoxin. NO20071706L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28
PCT/US2005/038410 WO2006060084A2 (en) 2004-10-28 2005-10-24 Coadministration of tigecycline and digoxin

Publications (1)

Publication Number Publication Date
NO20071706L true NO20071706L (no) 2007-05-24

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071706A NO20071706L (no) 2004-10-28 2007-03-30 Koadministrering av Tigecycline og Digoxin.

Country Status (18)

Country Link
US (1) US20060094668A1 (no)
EP (1) EP1804807B1 (no)
JP (1) JP2008518911A (no)
KR (1) KR20070069182A (no)
CN (1) CN101039679A (no)
AT (1) ATE415973T1 (no)
AU (1) AU2005310306A1 (no)
BR (1) BRPI0517406A (no)
CA (1) CA2582089A1 (no)
CR (1) CR9073A (no)
DE (1) DE602005011468D1 (no)
EC (1) ECSP077423A (no)
IL (1) IL182681A0 (no)
MX (1) MX2007005163A (no)
NO (1) NO20071706L (no)
RU (1) RU2007112409A (no)
WO (1) WO2006060084A2 (no)
ZA (1) ZA200703441B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20061107A1 (es) 2005-03-14 2006-12-08 Wyeth Corp Composiciones de tigeciclina y metodos para su preparacion
PE20070072A1 (es) * 2005-06-16 2007-02-25 Wyeth Corp Proceso de manufactura para tigeciclina como polvo reconstituible
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
US20100035845A1 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
SG11201906883SA (en) 2017-01-27 2019-08-27 Neurocrine Biosciences Inc Methods for the administration of certain vmat2 inhibitors
WO2019060322A2 (en) 2017-09-21 2019-03-28 Neurocrine Biosciences, Inc. HIGH DOSAGE VALBENAZINE FORMULATION AND COMPOSITIONS, METHODS AND KITS THEREOF
CN116492340A (zh) * 2017-10-10 2023-07-28 纽罗克里生物科学有限公司 施用某些vmat2抑制剂的方法

Also Published As

Publication number Publication date
WO2006060084A3 (en) 2006-07-20
WO2006060084A2 (en) 2006-06-08
US20060094668A1 (en) 2006-05-04
BRPI0517406A (pt) 2008-10-07
KR20070069182A (ko) 2007-07-02
ATE415973T1 (de) 2008-12-15
ZA200703441B (en) 2008-09-25
IL182681A0 (en) 2007-09-20
EP1804807B1 (en) 2008-12-03
EP1804807A2 (en) 2007-07-11
DE602005011468D1 (de) 2009-01-15
CN101039679A (zh) 2007-09-19
MX2007005163A (es) 2007-06-26
RU2007112409A (ru) 2008-12-10
ECSP077423A (es) 2007-05-30
AU2005310306A1 (en) 2006-06-08
JP2008518911A (ja) 2008-06-05
CA2582089A1 (en) 2006-06-08
CR9073A (es) 2007-08-28

Similar Documents

Publication Publication Date Title
NO20070988L (no) Vaksine for forebygging og behandling av HIV-infeksjon
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
NO20071706L (no) Koadministrering av Tigecycline og Digoxin.
DK1773361T3 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme og/eller infektioner og til forbedring af en intestinale funktionalitet
DK2109602T3 (da) Tetracyclinderivater til behandling af bakterielle, virale og parasitiske infektioner
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
LT1951272T (lt) Lactobacillus panaudojimas virusinių infekcijų gydymui
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
EP1753777A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING HIV INFECTION WITH TRIM5a
NO20052362D0 (no) Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
DK1919466T3 (da) Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat
DK1848415T3 (da) Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
DK1638589T3 (da) Kombinationsterapi med glatirameracetat og mitoxantron til behandling af multipel sklerose
WO2008118849A3 (en) Hiv-1 protease inhibitors
EA201171186A1 (ru) Сокристалл этравирина и никотинамида
DK1861080T3 (da) Idebenon til behandling af muskeldystrofier
NO20072285L (no) S-mirtazapin for behandling av hetetokter
MX2009011930A (es) Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
ATE433459T1 (de) Desoxo-nonadepsipeptide
ATE455789T1 (de) Substituierte nonadepsipeptide
IL180459A0 (en) Treatment of bacterial infections
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
DK1635847T3 (da) Behandling af symptomer forbundet med bakteriel vaginose

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application